Stockscreener 앱 받기
9.01
0.45%
0.04
Kura Oncology Inc 주식(KURA)의 최신 뉴스
Kura Oncology expands stock option plan - Investing.com
Kura Oncology (NASDAQ:KURA) Reaches New 52-Week LowWhat's Next? - MarketBeat
Kura Oncology Presents Deep Value At Today's Prices (Rating Upgrade) (NASDAQ:KURA) - Seeking Alpha
(KURA) Proactive Strategies - Stock Traders Daily
Kura Oncology's SWOT analysis: ziftomenib's promise buoys stock outlook By Investing.com - Investing.com UK
Kura Oncology's SWOT analysis: ziftomenib's promise drives stock outlook By Investing.com - Investing.com South Africa
Kura Oncology's SWOT analysis: ziftomenib's promise drives stock outlook - Investing.com India
Kura Oncology's SWOT analysis: ziftomenib's potential reshapes cancer stock landscape - Investing.com Canada
Kura Oncology’s (KURA) Overweight Rating Reaffirmed at Cantor Fitzgerald - Defense World
Kura Oncology, Inc. (NASDAQ:KURA) Q3 2024 Earnings Call Transcript - MSN
Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting - The Manila Times
Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib At American Society of Hematology Annual Meeting - Marketscreener.com
RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in Kura O - GuruFocus.com
Purple Biotech Secures $2.8 Million for Oncology Advancements - MSN
Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Why Is Kura Oncology, Inc. (KURA) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Insider Monkey
Kura Oncology Inc (NASDAQ: KURA) Gains 1.45% In Early Trade; What Lies Ahead? - Stocks Register
Kura Oncology to Host Virtual Investor Event on December 9, 2024 - The Manila Times
Kura Oncology to Host Investor Event on Ziftomenib Clinical Trial Data from ASH Meeting | KURA Stock News - StockTitan
ImmuneOnco Raises Funds for Cancer Research - MSN
Kura Oncology price target raised to $37 from $32 at H.C. Wainwright - MSN
Kura Oncology’s Collaboration with Kyowa Kirin - Global Legal Chronicle
How to Take Advantage of moves in (KURA) - Stock Traders Daily
Kura Oncology's SWOT analysis: precision cancer drug stock faces pivotal year - Investing.com India
Kura, Kyowa Kirin to co-develop ziftomenib in $1.49B deal - BioWorld Online
Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit - The Manila Times
Kura Oncology CEO to Present at JMP Securities Hematology & Oncology Summit | KURA Stock News - StockTitan
Cantor Fitzgerald Reaffirms Overweight Rating for Kura Oncology (NASDAQ:KURA) - Defense World
Kura Oncology (NASDAQ:KURA) Given Buy Rating at TD Cowen - Defense World
FY2025 EPS Estimate for Kura Oncology Raised by Analyst - Defense World
Leerink Partnrs Predicts Stronger Earnings for Kura Oncology - MarketBeat
Kura Oncology (NASDAQ:KURA) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World
Brokers Offer Predictions for Kura Oncology FY2025 Earnings - MarketBeat
Bank of America Issues Pessimistic Forecast for Kura Oncology (NASDAQ:KURA) Stock Price - Defense World
Kura Oncology partners Kyowa Kirin to advance AML treatment - MSN
Kura Crashes 37% After $1.53 Billion Deal Slams The Door On A Takeover - MSN
Kura Oncology (NASDAQ:KURA) Sees Large Volume Increase on Analyst Upgrade - MarketBeat
Kura Oncology, Inc. (KURA): Among the Most Promising Cancer Stocks According to Hedge Funds - Insider Monkey
Stifel cuts Kura Oncology target to $11 from $18, holds rating - Investing.com Canada
Firm Advises Kura Oncology on Global Strategic Collaboration with Kyowa Kirin - Wilson Sonsini
10 Most Promising Cancer Stocks According to Hedge Funds - Insider Monkey
Kura Oncology Stock Slips Following Collaboration With Kyowa: Retail Turns Extremely Bullish - MSN
Kura Oncology (NASDAQ:KURA) Given New $29.00 Price Target at Bank of America - MarketBeat
Earnings call: Kura Oncology reports on ziptamenib's progress in Q3 By Investing.com - Investing.com South Africa
Kura Oncology (NASDAQ:KURA) Shares Gap Down on Analyst Downgrade - Defense World
Earnings call: Kura Oncology reports on ziptamenib's progress in Q3 - Investing.com India
Kura Oncology inks global deal with Kyowa Kirin By Investing.com - Investing.com Nigeria
Analysts supportive of Kura/Kirin deal despite major selloff (update) - MSN
Health Care Roundup: Market Talk - MSN
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin - MedCity News
2.88%
2.65%
자본화:
|
볼륨(24시간):